braun getty wide

MLB official says Ryan Braun’s 50-game PED suspension is unlikely to be overturned

38 Comments

At some point within the next few weeks, Brewers outfielder Ryan Braun will have the opportunity to plead his innocence against a charge that he was taking performance-enhancing drugs around the start of the 2011 postseason. But he faces great odds.

The evidence against him comes in the form of a test, administered in either late September or early October, that had a positive reading for elevated levels of testosterone. That test was then passed along to the World Anti-Doping Agency lab in Montreal, where it was determined through further examination that the testosterone was synthetic — not produced by Braun’s body.

Braun might argue that the result was a false-positive, but an expert in the field of drug testing told Jeff Passan of Yahoo! Sports last month that those are “almost impossible” with today’s technology. Braun might say that result was triggered by a prescribed medication — something non-performance-enhancing — but how can he prove that and would it really matter if he could? The test showed insanely high levels of unnatural testosterone. However that testosterone arrived in Braun’s system, it’s against the rules for it to be there.

And even if Braun is telling the truth, and has never put synthetic testosterone into his body, a test that boasts an accuracy rating of nearly 100 percent says that the stuff was, at one point, present.

Which leads us to a report from Tom Haudricourt of the Milwaukee Journal Sentinel, who was told this weekend by an “MLB official familiar with the process” that Braun’s 50-game suspension is unlikely to be overturned. The 2011 NL MVP deserves his day in court, and he’ll get it later this month when he presents his case in front of an arbitrator, but it’s nearly certain that he’ll miss close to one-third of the 2012 campaign.

Aroldis Chapman reportedly has a $92 million offer on the table

CHICAGO, IL - JULY 28:  Aroldis Chapman #54 of the Chicago Cubs pitches in the 9th inning against the Chicago Cubs at Wrigley Field on July 28, 2016 in Chicago, Illinois. The Cubs defeated the White Sox 3-1.  (Photo by Jonathan Daniel/Getty Images)
Getty Images
Leave a comment

USA Today’s Bob Nightengale reports that a team — identity unknown — has offered $92 million to closer Aroldis Chapman.

We’re definitely in Crazy Town when it comes to relievers. Earlier this week the Giants made Mark Melancon the highest-paid reliever in history with a “mere” $62 million deal. Yesterday the Cubs traded for Wade Davis. Kenley Jansen is out on the market looking to get a deal larger than that. Chapman — who posted 1.55 ERA, 0.86 WHIP, and 90/18 K/BB ratio in 58 innings while helping the Cubs win the World Series — will,in all likelihood, top them all.

Teams reportedly in pursuit of Chapman: the Yankees, for whom he played last season before being traded to Chicago, the Nationals, Marlins and Dodgers.

Rangers sign Carlos Gomez to a one-year, $11.5 million deal

ARLINGTON, TX - OCTOBER 07:  Carlos Gomez #14 of the Texas Rangers looks on in the seventh inning against the Toronto Blue Jays in game two of the American League Divison Series at Globe Life Park in Arlington on October 7, 2016 in Arlington, Texas.  (Photo by Scott Halleran/Getty Images)
Scott Halleran/Getty Images
4 Comments

Ken Rosenthal of FOX Sports reports that the Rangers have signed outfielder Carlos Gomez to a one-year deal. Joel Sherman of the New York Post reports that Gomez will earn $11.5 million next season.

Gomez, 31, struggled with the Astros to a .594 OPS before the club released him in mid-August. The Rangers signed him shortly thereafter and were immediately rewarded. Gomez hit .284/.362/.543 with eight home runs and 24 RBI in 130 plate appearances through the end of the regular season.

As presently constructed, Gomez would likely take over in center field with Nomar Mazara handling left and Shin-Soo Choo in right.